RE:Canopy Growth Takes Major Loss Divesting C3 Cannabinoid Comp
The subsidiary is being sold off as Canopy looks to focus on a consumer packaged good model and recenters its focus to core markets. This simply means Canopy growth has data showing they will make way more money sticking to core market of fast moving sales of high demand THC and CBD products compared to C3 compounds which move slower because of less demand. They say when everyone cries you should be buying. Hold this stock long next few years will turn and shoot way up.